middle.news
Artrya Raises A$15M to Advance AI Heart Disease Tech in US Market
9:23am on Friday 14th of February, 2025 AEDT
•
Healthcare
Read Story
Artrya Raises A$15M to Advance AI Heart Disease Tech in US Market
9:23am on Friday 14th of February, 2025 AEDT
Key Points
A$15 million two-tranche placement at A$0.73 per share, a 15% discount to last trade
Funds allocated to product development, clinical trials, FDA clearance, and working capital
Salix platform offers real-time AI analysis of coronary CT angiography scans
Strategic agreements secured with major US hospital systems and Sonic Healthcare Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE